Agenus Inc. (AGEN)
Agenus Inc. - Agenus Announces Peer-Reviewed Publication LinkingBOT+BAL’s Durable Survival in MSS Metastatic Colorectal Cancer to Its Distinct Immune-Priming Mechanism
Agenus Inc. - Agenus Announces Peer-Reviewed Publication LinkingBOT+BAL’s Durable Survival in MSS Metastatic Colorectal Cancer to Its Distinct Immune-Priming Mechanism
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak signals • Minimal impact expected **Sentiment:** Neutral (50%) **Content type:** General